Friday, May 4, 2012

Osteoporosis Update

Alcohol
Moderate alcohol consumption has been shown to be positively associated with increased bone mineral density (BMD). However, other lifestyle choices have also been shown to have an effect on bone health. An American Journal of Clinical Nutrition study examined the association between alcohol intake and Bone Mineral Density in 3218 women around menopause and to determine whether any association is independent of other lifestyle choices. Women who consumed one drink per day of alcohol had a significantly greater femoral neck and lumbar spine Bone Mineral Density than did those who never consumed alcohol.

Healing Bone Injuries
A human-made package filled with nature's bone-building ingredients heals serious bone injuries faster than products currently available. Tested on sheep, the surgical elastic "implant device," essentially a wrapping that mimics bone's own sock-like sheath called periosteum, delivered stem cells, growth factors and other natural components of the periosteum to heal a defect that would not heal on its own if left untreated, as reported in journal PLoS One.

Scientists filled the pockets of one set of the devices with membranes made of collagen, which is a natural component of the periosteum; a second set was filled with collagen membranes seeded with cells that reside in the periosteum , and a third set with strips of periosteum. Both the collagen seeded sheets and the periosteum strips showed the most promising results.

Beyond bone, the device is flexible enough to be used in a broad array of applications including growing cartilage for orthopedics, to fuse vertebrae, as a delivery system for stem cells, antibiotics, transcription factors and more.

Diet Patterns
According to a study in British Journal of Nutrition, studies of individual nutrients or foods have revealed much about dietary influences on bone, but not in young adults. Researchers examined the relationship between dietary patterns, and bone mineral status, the collective term for bone mineral content (BMC) and bone mineral density (BMD) in young adults (20–25 years). Women in the top compared to the bottom fifth of the ‘Nuts and Meat’ pattern had greater femoral neck BMD and BMC. Men in the top compared to the bottom fifth of the ‘Refined Carbohydrate’ pattern had lower femoral BMC. In conclusion, adherence to a ‘Nuts and Meat’ dietary pattern may be associated with greater BMS in young women and a ‘Refined’ dietary pattern may be detrimental for bone health in young men.

Supplements 
Osteoporosis International published a recent study stating that "lifetime supplementation with vitamin K, vitamin D3, and calcium is likely to reduce bone fractures and increase survival in postmenopausal women. It would be a cost-effective intervention at commonly used thresholds, but further research on the effect of vitamin K on fractures is warranted. Compared to no supplementation, vitamin D(3) (800 IU/day) with calcium (1,200 mg/day), and vitamin K(2) (45 mg/day) with vitamin D(3) and calcium (at the same doses) were examined.

Adding vitamin K(2) to vitamin D(3) with calcium reduced the lifetime probability of at least one fracture by 25%, increased discounted survival by 0.7 quality-adjusted life-years and discounted costs by $8,956 per person. Lifetime supplementation with vitamin K, vitamin D(3), and calcium is likely to reduce fractures and increase survival in postmenopausal women. Given high uncertainty around the cost-effectiveness estimates, further research on the efficacy of vitamin K on fractures is warranted. 

Bonnie: we have seen more and more positive data on vitamin K for bone fracture prevention. While it is much easier to attain from diet (especially with ideal vegetable consumption) than vitamin D, we are getting closer to including it as a required supplemental nutrient, but are not there just yet. 

Safety (or Lack Thereof) of Current Osteoporosis Drug Therapy
This was taken verbatim from the Agency for Healthcare Research and Quality latest report on the challenges of treating osteoporosis.

What are the short- and long-term harms (adverse effects) of the above therapies?     
High Participants who took raloxifene showed higher odds for pulmonary embolism than did participants who took a placebo. Raloxifene participants also had greater odds of thromboembolic events.
High Estrogen and estrogen-progestin combination participants had higher odds of cerebrovascular accident (CVA) and thromboembolic events than did placebo participants.
High A pooled analysis of ten trials found an increased risk with raloxifene for myalgias, cramps, and limb pain.
High We categorized conditions such as acid reflux, esophageal irritation, nausea, vomiting, and heartburn as “mild upper GI events.” Our pooled analyses showed alendronate had a slightly increased risk of mild upper GI events. Alendronate participants also had higher odds of mild upper GI events in head-to-head trials vs. menopausal hormone therapy. Pooled analysis also showed alendronate users to be at an increased risk for mild GI events compared to denosumab. Denosumab was also associated with an increase in mild GI events.
Low A new systematic review of 15 placebo-controlled trials of calcium (administered for bone health in all trials but one) identified a statistically significant increase in the risk of myocardial infarction; however serious concerns have been expressed about possible bias.
Moderate Teriparatide-treated participants showed a significant increase in hypercalcemia.
Insufficient The literature is equivocal on the potential association between bisphosphonates and the risk of atrial fibrillation.
High One trial, one post hoc analysis of three trials, two large observational studies, and a review of 2,408 cases of osteonecrosis of the jaw in patients taking bisphosphonates for osteoporosis prevention or treatment found that the incidence of osteonecrosis of the jaw in this group was small, ranging from less than one to 28 cases per 100,000 person-years of treatment.
High Our pooled analysis of eight trials found an increased risk with raloxifene of hot flashes.

Limited data from clinical trials and observational studies support a possible association between bisphosphonate use and atypical subtrochanteric fractures of the femur. Data are not consistent, nevertheless these data were sufficient for FDA to issue a Warning regarding this possible adverse event.
Moderate A pooled analysis of three trials of teriparatide found an increased risk of headaches.
High A pooled analysis of four trials of denosumab found an increased risk of rash but no increase in the risk for injection-site reactions.
Moderate A small number of clinical trials have reported an increased risk of hypocalcemia in patients treated with alendronate and zoledronic acid.
Insufficient Four observational studies that assessed whether the use of an oral bisphosphonate is associated with an increased risk of esophageal cancer had mixed findings.
High A pooled analysis of four trials of denosumab found an increased risk for infection.

Steve: this also is a direct quote from the report: "Dietary and supplemental calcium and vitamin D, as well as weight bearing exercise, play important roles in preserving bone mass. Lifelong calcium intake is required for the acquisition of peak bone mass and for the subsequent maintenance of bone health. When serum calcium levels are inadequate, bone tissue is resorbed from the skeleton to maintain serum calcium at a constant level. Adequate vitamin D levels play a key role in calcium absorption, bone health, muscle performance, balance, and fall prevention."

No comments:

Post a Comment